Cover Image
市場調查報告書

過度色素沈積症:全球臨床實驗檢討

Hyper Pigmentation Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 296486
出版日期 內容資訊 英文 45 Pages
訂單完成後即時交付
價格
Back to Top
過度色素沈積症:全球臨床實驗檢討 Hyper Pigmentation Global Clinical Trials Review, H1, 2016
出版日期: 2016年05月31日 內容資訊: 英文 45 Pages
簡介

本報告提供過度色素沈積症治療藥相關臨床實驗的相關調查,臨床實驗數及被實驗人數,各階段狀況,正在開發的治療藥,主要的企業和研究所臨床實驗概要等彙整資料,為您概述為以下內容。

簡介

各地區的臨床實驗趨勢

  • 各國臨床實驗及實驗對象登記數
    • 亞太地區的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗

G7各國的臨床實驗:各進展狀況

E7各國的臨床實驗

E7各國的臨床實驗:各進展狀況

各方面的臨床實驗

  • 現在進行中的臨床實驗

各進展狀況臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與過度色素沈積症治療藥臨床實驗的主要企業

潛力治療藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Kasiak Research Pvt. Ltd.
    • Johnson & Johnson
    • Bayer AG
    • Sante Mernaud Pharmaceuticals Pvt. Ltd.
    • nPharmakon
    • Glenmark Pharmaceuticals Ltd.
    • Galderma S.A.
  • 主要大學/實驗室/醫院臨床實驗概要
    • The Indian Association of Dermatologists, Venereologists and Leprologists
    • Tabriz University of Medical Sciences
    • Callender Center for Clinical Research
    • Tohoku University Graduate School of Medicine, Department Of Surgery
    • Brazilian Center for Studies in Dermatology
    • Universidad Autonoma de San Luis Potosi
    • National Human Genome Research Institute
    • Mahidol University
    • National Taiwan University Hospital
    • Massachusetts General Hospital

主要的臨床實驗簡介(5件)

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3456CTIDB

GlobalData's clinical trial report, "Hyper Pigmentation Global Clinical Trials Review, H1, 2016" provides an overview of Hyper Pigmentation clinical trials scenario. This report provides top line data relating to the clinical trials on Hyper Pigmentation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hyper Pigmentation to Dermatology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hyper Pigmentation to Dermatology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hyper Pigmentation Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hyper Pigmentation Therapeutics, Global, Clinical Trials by Region, 2016*
  • Hyper Pigmentation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Hyper Pigmentation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Europe, Top Countries, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Hyper Pigmentation to Dermatology Clinical Trials, G7 Countries (%), 2016*
  • Hyper Pigmentation Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Hyper Pigmentation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Hyper Pigmentation to Dermatology Clinical Trials, E7 Countries (%), 2016*
  • Hyper Pigmentation Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Hyper Pigmentation Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Hyper Pigmentation Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Hyper Pigmentation Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Hyper Pigmentation Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Hyper Pigmentation Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Hyper Pigmentation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Hyper Pigmentation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Europe, Top Countries (%), 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016*
  • Proportion of Hyper Pigmentation to Dermatology Clinical Trials, G7 Countries (%), 2016*
  • Hyper Pigmentation Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Hyper Pigmentation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Hyper Pigmentation to Dermatology Clinical Trials, E7 Countries (%), 2016*
  • Hyper Pigmentation Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Hyper Pigmentation Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Hyper Pigmentation Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Hyper Pigmentation Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Hyper Pigmentation Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Hyper Pigmentation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top